Kähkönen TE, Galabova G, Yang R, Wen J, Thormann M, Halleen JM 2025 OBP-004, a novel small-molecule dual inhibitor of CDK9/13, reduces bone, brain, lung and lymph node metastases in vivo, with highest potency on bone metastases. Mol Cancer Ther 24 (10_Supplement):A085. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 22-26, 2025, Boston, MA.
If you are interested to learn more,
see our services or contact us directly.
